This case study describes how Sygnature Discovery, a world‑leading drug‑discovery CRO, adopted a SaaS R&D platform to streamline operations and improve customer service. The organization needed a solution that could support diverse research programs, enhance collaborative lab workflows, improve data management, and strengthen communication with clients. By implementing the Dotmatics ELN and Data Discovery Platform, Sygnature achieved a balance between standardization and flexibility. The platform supports experiment design, assay analysis, inventory and request management, chemical and biological entity registration, data search, and real-time reporting. As a result, teams gained flexible, client‑specific ELN protocols within a standardized framework, enabling more efficient workflows, bet

Join for free to read